Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering

Advanced Drug Delivery Reviews - Tập 59 - Trang 234-248 - 2007
W.J.E.M. Habraken1, J.G.C. Wolke1, J.A. Jansen1
1Department of Periodontology and Biomaterials, Radboud University Nijmegen Medical Center, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands

Tài liệu tham khảo

Barsoum, 1997, Fundamentals of ceramics, 2 Whitters, 1999, Dental materials: 1997 literature review, J. Dent., 27, 401, 10.1016/S0300-5712(99)00007-X Block, 2000, Clinical indications of calcium-phosphate biomaterials and related composites for orthopeadic procedures, Calcif. Tissue Int., 66, 234, 10.1007/PL00005839 Taksali, 2004, Material considerations for invertebral disc replacement implants, Spine J., 4, 231S, 10.1016/j.spinee.2004.07.012 Katti, 2004, Biomaterials in total joint replacement, Colloids Surf., B Biointerfaces, 39, 133, 10.1016/j.colsurfb.2003.12.002 Heini, 2001, Bone substitutes in vertebroplasty, Eur. Spine J., 10, S205, 10.1007/s005860100308 Gladstone, 1995, Implants for cranioplasty, Otolaryngol. Clin. North Am., 28, 381, 10.1016/S0030-6665(20)30552-1 LeGeros, 2002, Properties of osteoconductive biomaterials: calcium phosphates, Clin. Orthop. Relat. Res., 395, 81, 10.1097/00003086-200202000-00009 Kenny, 2003, Bone cements and fillers: a review, J. Mater. Sci., Mater. Med., 14, 923, 10.1023/A:1026394530192 Thomas, 2005, Bioactive glass three decades on, J. Long-Term Eff. Med. Implants, 15, 585, 10.1615/JLongTermEffMedImplants.v15.i6.20 Karageorgiou, 2005, Porosity of 3D biomaterial scaffolds and osteogenesis, Biomaterials, 26, 5474, 10.1016/j.biomaterials.2005.02.002 Seeherman, 2005, Delivery of bone morphogenic proteins for orthopedic tissue regeneration, Cytokine Growth Factor Rev., 16, 329, 10.1016/j.cytogfr.2005.05.001 Ginebra, 2006, Calcium phosphate cements as bone drug delivery systems: a review, J. Control. Release., 113, 102, 10.1016/j.jconrel.2006.04.007 Jansen, 2005, Growth factor-loaded scaffolds for bone engineering, J. Control. Release., 101, 127, 10.1016/j.jconrel.2004.07.005 Yuan, 2006, Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds, Tissue Eng., 12, 1607, 10.1089/ten.2006.12.1607 Hutmacher, 2000, Scaffolds in tissue engineering bone and cartilage, Biomaterials, 21, 2529, 10.1016/S0142-9612(00)00121-6 Muzzarelli, 2002, Natural and artificial chitosan–inorganic composites, J. Inorg. Biochem., 92, 89, 10.1016/S0162-0134(02)00486-5 Lawson, 1998, Collagen–calcium phosphate composites, Proc. Inst. Mech. Eng., H J. Eng. Med., 212, 413, 10.1243/0954411981534187 Mastrogiacomo, 2006, Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate ceramics, Biomaterials, 27, 3230, 10.1016/j.biomaterials.2006.01.031 Wilson, 2004, Design and fabrication of standardized hydroxyapatite scaffolds with a defined micro-architecture by rapid prototyping for bone-tissue-engineering research, J. Biomed. Mater. Res., A, 68, 123, 10.1002/jbm.a.20015 Almiral, 2004, Fabrication of low temperature macroporous hydroxyapatite scaffolds by foaming and hydrolysis of an alpha-CP paste, Biomaterials, 25, 3671, 10.1016/j.biomaterials.2003.10.066 Kruyt, 2006, The effect of cell-based bone tissue engineering in a goat transverse process model, Biomaterials, 27, 5099, 10.1016/j.biomaterials.2006.05.048 Stallmann, 2006, In vitro gentamycin release from commercially available calcium–phosphate bone substitutes influence of carrier type on duration of the release profile, BMC Musculosket. Disord., 7, 1 Guicheux, 1998, Growth hormone-loaded macroporous calcium phosphate ceramic: in vitro biopharmaceutical characterization and preliminary in vivo study, J. Biomed. Mater. Res., 40, 560, 10.1002/(SICI)1097-4636(19980615)40:4<560::AID-JBM7>3.0.CO;2-D Kimakhe, 1999, Biological activities of sustained polymixin B release from calcium phosphate biomaterial prepared by dynamic compaction: an in vitro study, J. Biomed. Mater. Res., 47, 18, 10.1002/(SICI)1097-4636(199910)47:1<18::AID-JBM3>3.0.CO;2-T Ziegler, 2002, Adsorption and release properties of growth factors from biodegradable implants, J. Biomed. Mater. Res., 59, 422, 10.1002/jbm.1258 Yuan, 2002, A comparison of the osteoconductive potential of two calcium phosphate ceramics implanted intramuscularly in goats, J. Mater. Sci., Mater. Med., 13, 1272, 10.1023/A:1021191432366 Habibovic, 2006, Osteoinduction by biomaterials—Physicochemical and structural influences, J. Biomed. Mater. Res., A, 77, 747, 10.1002/jbm.a.30712 Jansen, 2005, Injectable calcium phosphate cement for bone repair and implant fixation, Orthop. Clin. North Am., 36, 89, 10.1016/j.ocl.2004.06.014 Bohner, 2005, Technological issues for the development of more efficient calcium phosphate bone cements: a critical assessment, Biomaterials, 26, 6423, 10.1016/j.biomaterials.2005.03.049 Chow, 1991, Self-setting CaP cements, Mater. Res. Soc. Symp. Proc., 179, 3 Xu, 2006, Injectable and macroporous calcium phosphate scaffold, Biomaterials, 27, 4279, 10.1016/j.biomaterials.2006.03.001 Del Real, 2002, A new method to produce macropores in calcium phosphate cements, Biomaterials, 23, 3673, 10.1016/S0142-9612(02)00101-1 Del Real, 2003, In vivo bone response to porous calcium phosphate cement, J. Biomed. Mater. Res., A, 65, 30, 10.1002/jbm.a.10432 Ginebra, 2006, Factors affecting the structure and properties of an injectable self-setting calcium phosphate foam, J. Biomed. Mater. Res., A, 80, 351, 10.1002/jbm.a.30886 Link, 2007, The cytocompatibility and early osteogenic characteristics of an injectable calcium phosphate cement, Tissue Eng., 13, 10.1089/ten.2006.0015 Blom, 2002, Transforming growth factor-β1 incorporation in an α-tricalcium phosphate monoxide cement: release characteristics and physicochemical properties, Biomaterials, 23, 1261, 10.1016/S0142-9612(01)00246-0 Ruhé, 2006, In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin, J. Mater. Sci., Mater. Med., 17, 919, 10.1007/s10856-006-0181-z Stallmann, 2003, Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1–11(hLF1–11) from calcium phosphate bone substitutes, J. Antimicrob. Chemother., 52, 853, 10.1093/jac/dkg443 Seeherman, 2006, rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations, J. Bone Jt. Surg., Am. Vol., 88, 144, 10.2106/JBJS.D.02453 Ruhé, 2004, Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits, Biomaterials, 25, 2123, 10.1016/j.biomaterials.2003.09.007 Kroese-Deutman, 2005, Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits, Biomaterials, 26, 1131, 10.1016/j.biomaterials.2004.04.021 Blom, 2001, Transforming growth factor-beta1 incorporated in calcium phosphate cement stimulates osteotransductivity in rat calvarial bone defects, Clin. Oral Implants Res., 12, 609, 10.1034/j.1600-0501.2001.120609.x L.L. Hench, O. Anderson, In: An introduction to Bioceramics, Chapter 3: Bioactive glasses. 1993, pp. 41–61. Zhong, 2000, Processing and properties of sol–gel bioactive glasses, J. Biomed. Mater. Res., B Appl. Biomater., 53, 694, 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6 Kokubo, 2003, Novel bioactive materials with different mechanical properties, Biomaterials, 24, 2161, 10.1016/S0142-9612(03)00044-9 Ebisawa, 1997, Bioactivity of ferrimagnetic glass–ceramics in the system FeO–Fe2O3–CaO–SiO2, Biomaterials, 18, 1277, 10.1016/S0142-9612(97)00067-7 Yuan, 2001, Bone induction by porous glass ceramics made from Bioglass®, J. Biomed. Mater. Res., B Appl. Biomater., 58, 270, 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2 Chen, 2006, 45S5 Bioglass®-derived glass–ceramic scaffolds for bone tissue engineering, Biomaterials, 27, 2414, 10.1016/j.biomaterials.2005.11.025 Kaufmann, 2000, Effect of varying physical properties of porous, surface modified bioactive glass 45S5 on osteoblast proliferation and maturation, J. Biomed. Mater. Res., 52, 783, 10.1002/1097-4636(20001215)52:4<783::AID-JBM24>3.0.CO;2-J Sepulveda, 2002, In vitro dissolution of melt-derived 45S5 and sol–gel derived 58S bioactive glasses, J. Biomed. Mater. Res., 61, 301, 10.1002/jbm.10207 Cerruti, 2005, An analytical model for the dissolution of different particle size samples of Bioglass® in TRIS-buffered solution, Biomaterials, 26, 4903, 10.1016/j.biomaterials.2005.01.013 Santos, 1999, Sol–gel derived carrier for the controlled release of proteins, Biomaterials, 20, 1695, 10.1016/S0142-9612(99)00066-6 Domingues, 2004, Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with β-cyclodextrin, Biomaterials, 25, 327, 10.1016/S0142-9612(03)00524-6 Navarro, 2004, Development and cell response of a new biodegradable composite scaffold for guided bone regeneration, J. Mater. Sci., Mater. Med., 15, 419, 10.1023/B:JMSM.0000021113.88702.9d Niemela, 2005, Self-reinforced composites of bioresorbable polymer and bioactive glass with different bioactive glass contents. Part I: initial mechanical properties and bioactivity, Acta Biomater., 1, 235, 10.1016/j.actbio.2004.11.002 Yao, 2005, Solution-mediated effect of bioactive glass in poly(lactic co glycolic)-bioactive glass composites on osteogenesis of marrow stromal cells, J. Biomed. Mater. Res., A, 75, 794, 10.1002/jbm.a.30494 Zhang, 1999, Poly(α-hydroxyl acids)/hydroxyapatite porous composites for bone–tissue engineering. I. Preparation and morphology, J. Biomed. Mater. Res., 44, 446, 10.1002/(SICI)1097-4636(19990315)44:4<446::AID-JBM11>3.0.CO;2-F Shikinami, 1999, Bioresorbable devices made of forged composites of hydroxyapatite (HA) particles and poly-l-lactide (PLLA): Part I. Basic characteristics, Biomaterials, 20, 859, 10.1016/S0142-9612(98)00241-5 Shikinami, 2005, The complete process of bioresorption and bone replacement using devices made of forged composites of raw hydroxyapatite particles/poly l-lactide (F-u-HA/PLLA), Biomaterials, 26, 5542, 10.1016/j.biomaterials.2005.02.016 Mondrinos, 2006, Porogen-based solid freeform fabrication of polycaprolactone–calcium phosphate scaffolds for tissue engineering, Biomaterials, 27, 4399, 10.1016/j.biomaterials.2006.03.049 Ignjatovic, 2006, Cytotoxicity and fibroblast properties during in vitro test of biphasic calcium phosphate/poly-dl-lactide-co-glycolide biocomposites and different phosphate materials, Microsc. Res. Tech., 69, 10.1002/jemt.20374 Ambrosio, 2001, A novel amorphous calcium phosphate polymer ceramic for bone repair: I. synthesis and characterization, J. Biomed. Mater. Res., B Appl. Biomater., 58, 295, 10.1002/1097-4636(2001)58:3<295::AID-JBM1020>3.0.CO;2-8 Ignatius, 2001, In vivo investigation on composites made of resorbable ceramics and poly(lactide) used as bone graft substitutes, J. Biomed. Mater. Res., 58, 701, 10.1002/jbm.10024 Soriano, 2000, Formulation of calcium phosphates /poly (d,l-lactide) blends containing gentamycin for bone implantation, J. Control. Release., 68, 121, 10.1016/S0168-3659(00)00251-0 Lu, 2000, Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles, J. Biomed. Mater. Res., 50, 440, 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G Schwach, 2003, Biodegradable microparticles for sustained release of a new GnRH antagonist—part I: Screening commercial PLGA and formularion technologies, Eur. J. Pharm. Biopharm., 56, 327, 10.1016/S0939-6411(03)00096-1 Simon, 2002, Preliminary report on the biocompatibility of a moldable, resorbable, composite bone graft consisting of calcium phosphate cement and poly(lactide-co-glycolide) microspheres, J. Orthop. Res., 20, 473, 10.1016/S0736-0266(01)00140-1 Ruhé, 2003, rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composites, J. Bone Jt. Surg., Am. Vol., 85A, 75, 10.2106/00004623-200300003-00013 Habraken, 2006, Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics, J. Biomater. Sci., Polym. Ed., 17, 1057, 10.1163/156856206778366004 Ruhé, 2005, Biocompatibility and degradation of poly(DL-lactic-co-glycolic acid)/Calcium phosphate cement composites, J. Biomed. Mater. Res., A, 74, 533, 10.1002/jbm.a.30341 Link, 2006, Mechanical evaluation of implanted calcium phosphate cement incorporated with PLGA microparticles, Biomaterials, 27, 4941, 10.1016/j.biomaterials.2006.05.022 Ruhé, 2006, Porous poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects, Tissue Eng., 12, 789, 10.1089/ten.2006.12.789 Ruhé, 2005, Controlled release of rhBMP-2 loaded poly(DL-lactic-co-glycolic acid)/Calcium phosphate cement composites in vivo, J. Control. Release., 106, 162, 10.1016/j.jconrel.2005.04.018 Schnieders, 2006, Controlled release of gentamycin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement, Biomaterials, 27, 4239, 10.1016/j.biomaterials.2006.03.032 Takahashi, 2005, Enhanced osteoinduction by controlled release of bone morphogenic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate, Biomaterials, 26, 4856, 10.1016/j.biomaterials.2005.01.012 Kim, 2004, Hydroxyapatite and gelatin composite foams processed via novel freeze-drying and crosslinking for use as temporary hard tissue scaffolds, J. Biomed. Mater. Res., A, 72, 136 Shibata, 2005, Colloidal β-tricalcium phosphate prepared by discharge in a modified body fluid facilitates synthesis of collagen composites, J.Dent.Res., 84, 827, 10.1177/154405910508400909 Lin, 1998, Biological effects and cytotoxicity of the composite composed by tricalcium phosphate and glutaraldehyde-cross-linked gelatin, Biomaterials, 19, 905, 10.1016/S0142-9612(97)00202-0 Du, 2000, Formation of calcium phosphate/collagen composites through mineralization of collagen matrix, J. Biomed. Mater. Res., 50, 518, 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W Tampieri, 2003, Porous phosphate–gelatin composite as bone graft with drug delivery function, J. Mater. Sci., Mater. Med., 14, 623, 10.1023/A:1024027125003 Yamamoto, 2001, Controlled release of growth factors based on biodegradation of gelatin hydrogel, J Biomater Sci Polymer Edn., 12, 77, 10.1163/156856201744461 Itoh, 2004, Development of a hydroxyapatite/collagen nanocomposite as a medical device, Cell Transplant., 13, 451, 10.3727/000000004783983774 Itoh, 2001, J Biomed Mater Res, 54, 445, 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9 Bigi, 2004, Effect of added gelatin on the properties of calcium phosphate cement, Biomaterials, 25, 2893, 10.1016/j.biomaterials.2003.09.059 Bigi, 2004, A biomimetic gelatin-calcium phosphate bone cement, Int. J. Artif. Organs, 27, 664, 10.1177/039139880402700804 Bigi, 2006, Normal and osteopenic bone-derived osteoblast response to a biomimetic gelatin–calcium phosphate bone cement, J. Biomed. Mater. Res., A, 78, 739, 10.1002/jbm.a.30765 Fujishiro, 2001, Preparation and compressive strength of α-tricalcium phosphate/gelatin gel composite cement, J. Biomed. Mater. Res., 54, 525, 10.1002/1097-4636(20010315)54:4<525::AID-JBM80>3.0.CO;2-# Bigi, 2000, Biomimetic growth of hydroxyapatite on gelatin films doped with sodium polyacrylate, Biomacromolecules, 1, 752, 10.1021/bm0055854 Rammelt, 2004, Collagen type I increases bone remodeling around hydroxyapatite implants in the rat tibia, Cells Tissues Organs, 178, 146, 10.1159/000082245 Knepper-Nicolai, 2002, Influence of osteocalcin and collagen I on the mechanical and biological properties of Biocement D, Biomol. Eng., 19, 227, 10.1016/S1389-0344(02)00036-9 Hempel, 2004, Proliferation and differentiation of osteoblasts on Biocement D modified with collagen type I and citric acid, J. Biomed. Mater. Res. Appl. Biomat., 71B, 130, 10.1002/jbm.b.30082 Lode, 2007, Calcium phosphate bone cements, functionalized with VEGF: Release kinetics and biological activity, J. Biomed. Mater. Res., 10.1002/jbm.a.31024 Le Nihouannen, 2006, Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering, Biomaterials, 27, 2716, 10.1016/j.biomaterials.2005.11.038 Jegoux, 2005, In vivo biological performance of composites combining micro-macroporous biphasic calcium phosphate granules and fibrin sealant, Arch. Orthop. Trauma Surg., 125, 153, 10.1007/s00402-004-0748-4 Knesser, 2005, Fibrin gel-immobilized primary osteoblasts in calcium phosphate bone cement: in vivo evaluation with regard to application as injectable biological bone substitute, Cells Tissues Organs, 179, 158, 10.1159/000085951 Vaz, 2003, Casein and soybean protein-based thermoplastics and composites as alternative biodegradable polymers for biomedical applications, J. Biomed. Mater. Res., A, 65, 60, 10.1002/jbm.a.10416 Lin, 2006, Calcium phosphate cement reinforced by polypeptide copolymers, J. Biomed. Mater. Res. Appl. Biomat., 76, 432, 10.1002/jbm.b.30392 Leroux, 1999, Effects of various adjuvants (lactic acid, glycerol and chitosan) on the injectability of a calcium phosphate cement, Bone., 25, 31S, 10.1016/S8756-3282(99)00130-1 Takagi, 2003, Properties of elastomeric calcium phosphate cement–chitosan, Dent Mater., 19, 797, 10.1016/S0109-5641(03)00028-9 Xu, 2002, Processing and properties of strong and non-rigid calcium phosphate cement, J.Dent.Res., 81, 219, 10.1177/154405910208100315 Xu, 2005, Fast setting calcium phosphate–chitosan scaffold: mechanical properties and biocompatibility, Biomaterials, 26, 1337, 10.1016/j.biomaterials.2004.04.043 Takechi, 2002, The in vitro antibiotic release from anti-washout apatite cement using chitosan, J. Mater. Sci., Mater. Med., 13, 973, 10.1023/A:1019816830793 Lee, 2000, Tissue engineered bone formation using chitosan/tricalcium phosphate sponges, J Periodontol., 71, 410, 10.1902/jop.2000.71.3.410 Zhang, 2004, Cell growth and function on calcium phosphate reinforced chitosan scaffolds, J. Mater. Sci., Mater. Med., 15, 255, 10.1023/B:JMSM.0000015485.94665.25 Zhang, 2002, Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release, J. Biomed. Mater. Res., 62, 378, 10.1002/jbm.10312 Lee, 2000, The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier, J Periodontol., 71, 418, 10.1902/jop.2000.71.3.418 Daculsi, 1999, Biphasic calcium phosphate/hydrosoluble polymer composites: a new concept for bone and dental substitution biomaterials, Bone., 25, 59S, 10.1016/S8756-3282(99)00135-0 Fellah, 2006, Bone repair using a new injectable self-crosslinkable bone substitute, J. Orthop. Res., 24, 628, 10.1002/jor.20125 Burguera, 2006, Injectable and rapid-setting calcium phosphate bone cement with dicalcium phosphate dihydrate, J. Biomed. Mater. Res. Appl. Biomat., 77, 126, 10.1002/jbm.b.30403 Ongpipattanakul, 1997, Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler, J. Biomed. Mater. Res., 36, 295, 10.1002/(SICI)1097-4636(19970905)36:3<295::AID-JBM4>3.0.CO;2-9 Boesel, 2004, The behavior of novel hydrophilic composite bone cements in simulated body fluids, J. Biomed. Mater. Res. Appl. Biomat., 70, 368, 10.1002/jbm.b.30055 Liljensten, 2000, Hydroxyapatite granule/carrier composites promote new bone formation in cortical defects, Clin. Implant Dent. Relat. Res., 2, 50, 10.1111/j.1708-8208.2000.tb00106.x Augst, 2006, Alginate hydrogels as biomaterials, Macromol. Biosci., 6, 623, 10.1002/mabi.200600069 Khairoun, 1999, Addition of cohesion promotors to calcium phosphate cements, Biomaterials, 20, 393, 10.1016/S0142-9612(98)00202-6 Peter, 1999, crosslinking characteristics of an injectable poly(propylene fumarate)/β-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement, J. Biomed. Mater. Res., 44, 314, 10.1002/(SICI)1097-4636(19990305)44:3<314::AID-JBM10>3.0.CO;2-W Charvet, 2000, Mechanical and fracture behaviour of a fiber-reinforced bioabsorbable material for orthopeadic applications, J. Mater. Sci., Mater. Med., 11, 101, 10.1023/A:1008945017668 Misra, 2006, Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications, Biomacromolecules, 7, 2249, 10.1021/bm060317c Qiu, 2006, A citric acid based hydroxyapatite composite for orthopeadic implants, Biomaterials, 27, 5845, 10.1016/j.biomaterials.2006.07.042 Mickiewicz, 2002, Polymer-calcium phosphate cement composites for bone substitutes, J. Biomed. Mater. Res., 61, 581, 10.1002/jbm.10222 dos Santos, 2003, Fiber-enriched double-setting calcium phosphate bone cement, J. Biomed. Mater. Res., A, 65, 244, 10.1002/jbm.a.10474 Xu, 2000, Reinforcement of a self-setting calcium phosphate cement with different fibers, J. Biomed. Mater. Res., 52, 107, 10.1002/1097-4636(200010)52:1<107::AID-JBM13>3.0.CO;2-0